A novel cause of erythromelalgia due to pseudoephedrine

被引:0
作者
Kravvas, Georgios [1 ]
Aboukhatwah, Nada [2 ]
Ali, Lana [3 ]
Bray, Adam P. [3 ]
机构
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Dermatol, London, England
[2] Whittington Hlth NHS Fdn Trust, Dept Dermatol, London, England
[3] Univ Hosp Bristol NHS Fdn Trust, Dept Dermatol, London, England
来源
OXFORD MEDICAL CASE REPORTS | 2024年 / 2024卷 / 04期
关键词
erythromelalgia; neuropathic pain; pseudoephedrine; drug reaction; burning; desquamation;
D O I
10.1093/omcr/omae037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Erythromelalgia is a rare, highly debilitating disorder characterised by severe episodes of discomfort, erythema, and desquamation of the extremities. Its causes include genetic factors, medications, and several underlying medical conditions. This paper describes a novel cause of erythromelalgia through a case report and literature review.Case description A 47-year-old Caucasian man presented with a two-year history of intermittent pain, redness and desquamation of the hands. He experienced several such episodes, each lasting 3-4 weeks. A skin biopsy confirmed the diagnosis of erythromelalgia. After several recurrences, he admitted to the intermittent use of pseudoephedrine as a nasal decongestant, which coincided with the episodes of erythromelalgia. Complete resolution of symptoms was reported on cessation of this medication.Conclusion Pseudoephedrine has been reported to cause a wide range of cutaneous reactions but has not been known to precipitate erythromelalgia. Recognition of this rare side effect may offer early diagnosis and reduced morbidity.
引用
收藏
页码:171 / 172
页数:2
相关论文
共 7 条
  • [1] Pseudoephedrine-induced acute generalized exanthematous pustulosis
    Ben Salem, Chaker
    Slim, Raoudha
    Denguezli, Mohamed
    Sriha, Badreddine
    Hmouda, Houssem
    Bouraoui, Kamel
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (04) : 418 - 419
  • [2] Erythromelalgia: New theories and new therapies
    Cohen, JS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (05) : 841 - 847
  • [3] The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32
    Drenth, JPH
    Finley, WH
    Breedveld, GJ
    Testers, L
    Michiels, JJ
    Guillet, G
    Taieb, A
    Kirby, RL
    Heutink, P
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) : 1277 - 1282
  • [4] Erythromelalgia: a clinical study of 87 cases
    Kalgaard, OM
    Seem, E
    Kvernebo, K
    [J]. JOURNAL OF INTERNAL MEDICINE, 1997, 242 (03) : 191 - 197
  • [5] Kalgaard OM., Erythromelalgia: Clinical aspects, pathology and therapy
  • [6] Secondary erythromelalgia: a tryptophan dietary supplement-induced case associated with elevated 5-hydroxyindoleacetic acid (5HIAA) urinary levels
    Michelerio, Andrea
    Derlino, Federica
    Brazzelli, Valeria
    Vassallo, Camilla
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (01) : 83 - 85
  • [7] Shear NH., 2020, Litt's Drug Eruption Reaction Manual, V26th, P1